Bimatoprost is indicated for the reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension in adults (as monotherapy or as adjunctive therapy to beta-blockers).
For this indication, competent medicine agencies globally authorize below treatments:
Ophthalmic
1 - 1 {drops}
From 1 To 1 {drops} once every day
The recommended dose is one drop in the affected eye(s) once daily, administered in the evening. The dose should not exceed once daily, as more frequent administration may lessen the intraocular pressure lowering effect.